These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24903950)

  • 1. Update on cost-effectiveness of a 12-dose regimen for latent tuberculous infection at new rifapentine prices.
    Shepardson D; MacKenzie WR
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):751. PubMed ID: 24903950
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine.
    Frick M; Seaworth B; McKenna L; Elnour T; Lee C
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1386. PubMed ID: 25299876
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of treating latent tuberculous infection: a step towards elimination?
    Diel R; Loddenkemper R; Sotgiu G; Migliori GB
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1515. PubMed ID: 24200259
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.
    Shepardson D; Marks SM; Chesson H; Kerrigan A; Holland DP; Scott N; Tian X; Borisov AS; Shang N; Heilig CM; Sterling TR; Villarino ME; Mac Kenzie WR
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1531-7. PubMed ID: 24200264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.
    Denholm JT; McBryde ES; Eisen D; Street A; Matchett E; Chen C; Shultz TR; Biggs B; Leder K
    Intern Med J; 2017 Dec; 47(12):1433-1436. PubMed ID: 29224209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.
    Holland DP; Sanders GD; Hamilton CD; Stout JE
    PLoS One; 2011; 6(7):e22276. PubMed ID: 21789248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
    Huang YW; Yang SF; Yeh YP; Tsao TC; Tsao SM
    Medicine (Baltimore); 2016 Aug; 95(34):e4126. PubMed ID: 27559940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    Doan TN; Fox GJ; Meehan MT; Scott N; Ragonnet R; Viney K; Trauer JM; McBryde ES
    J Antimicrob Chemother; 2019 Jan; 74(1):218-227. PubMed ID: 30295760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection.
    Pina JM; Clotet L; Ferrer A; Sala MR; Garrido P; Salleras L; Domínguez A
    Respir Med; 2013 May; 107(5):768-77. PubMed ID: 23490222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cost-effectiveness of rifampin vs. isoniazid for latent tuberculosis: implications for future clinical trials.
    Esfahani K; Aspler A; Menzies D; Schwartzman K
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1340-6. PubMed ID: 22283892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course isoniazid plus rifapentine therapy for latent tuberculosis in Brazil.
    Croda J
    Rev Soc Bras Med Trop; 2015; 48(5):505-6. PubMed ID: 26516957
    [No Abstract]   [Full Text] [Related]  

  • 12. Completion Rates, Adverse Effects, and Costs of a 3-Month and 9-Month Treatment Regimen for Latent Tuberculosis Infection in California Inmates, 2011-2014.
    Wheeler C; Mohle-Boetani J
    Public Health Rep; 2019; 134(1_suppl):71S-79S. PubMed ID: 31059418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.
    Holland DP; Sanders GD; Hamilton CD; Stout JE
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1055-60. PubMed ID: 19299495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is isoniazid for 6 months more cost-effective than isoniazid for 9 months?
    Pina JM; Clotet L; Sala MR; Ferrer A; Arias C; Domínguez A
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):768-73. PubMed ID: 22508169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of latent tuberculosis infection.
    Parekh MJ; Schluger NW
    Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings.
    Bastos ML; Campbell JR; Oxlade O; Adjobimey M; Trajman A; Ruslami R; Kim HJ; Baah JO; Toelle BG; Long R; Hoeppner V; Elwood K; Al-Jahdali H; Apriani L; Benedetti A; Schwartzman K; Menzies D
    Ann Intern Med; 2020 Aug; 173(3):169-178. PubMed ID: 32539440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
    Chen YM; Liao TL; Chen HH; Chen DY
    Ann Rheum Dis; 2018 Nov; 77(11):1688-1689. PubMed ID: 29674320
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid preventive therapy in medium-incidence settings: the price is right.
    Stout JE; Andrews JR
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1388. PubMed ID: 25517800
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice.
    Fröberg G; Jansson L; Bruchfeld J
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30409821
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of latent tuberculosis infection: An update.
    Lobue P; Menzies D
    Respirology; 2010 May; 15(4):603-22. PubMed ID: 20409026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.